Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlowtech Fluid. Regulatory News (FLO)

Share Price Information for Flowtech Fluid. (FLO)

Share Price is delayed by 15 minutes
Get Live Data
57.00    -2.90 (-4.84%)
Bid:
57.00
Ask:
59.80
Spread: 2.80 (4.912%)
Market Cap: £46.42m
FLO Live PriceLast checked at - London Stock Exchange

Intraday Flowtech Fluid. Share Chart

Board Appointment

5 Jan 2005 07:00

Flomerics Group PLC05 January 2005 5 January 2005 Flomerics Group PLC ("Flomerics" or the "Company") Appointment of Chief Operating Officer The board of Flomerics Group PLC, supplier of analysis software to electronicsindustries, is delighted to announce the appointment of Gary Christopher Carter,aged 45, as Chief Operating Officer with effect from 10 January 2005. It isexpected that Gary will be appointed to the board of Flomerics Group PLC soonafter. As announced in our interim results in July this year, David Tatchell, thecurrent CEO, intends to relinquish the position before he reaches the age of 60in 2006. It is intended that Gary will take over as CEO within this time scale. Gary joins the Company from ANSYS, Inc, a major US-based Computer AidedEngineering ("CAE") company, where he was Managing Director and Vice Presidentof European Sales. David Tatchell, Chief Executive, commented: "Gary has an outstanding 10 year track record in sales leadership and seniormanagement in the CAE industry, and, added to this, brings an in-depthappreciation of the engineering and technical aspects of Flomerics' business.Most importantly, Gary's experience in growing a significantly larger softwareanalysis business will be invaluable to Flomerics in achieving its growthstrategy." Gary Carter commented: "Ever since I first started out in the CAE business, Flomerics has stood out asbeing synonymous with simulation software in the electronics industries. I amtherefore very excited by this opportunity and I am looking forward to workingwith the team that has been behind this success as we address the challenges ofthe future." Mr Carter's current and previous directorships over the past five years are asfollows: Current ANSYS Europe Limited - previously ASN Systems Limited ANSYS France Previous CFX Limited There are no other matters to be disclosed in relation to Schedule 2 paragraph Fof the AIM Rules. For further information please contact: FlomericsDavid Tatchell Chief Executive 020 8941 8810Chris Ogle Finance Director & Company Secretary Buchanan CommunicationsTim Thompson / Nicola Cronk 020 7466 5000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th Nov 20217:00 amRNSHolding(s) in Company
10th Nov 20214:09 pmRNSHolding(s) in Company
3rd Nov 20214:41 pmRNSSecond Price Monitoring Extn
3rd Nov 20214:36 pmRNSPrice Monitoring Extension
7th Sep 20217:00 amRNS2021 HALF-YEAR REPORT - six months to 30 June 2021
3rd Aug 20217:00 amRNSGroup Trading Update & Notice of Half-year Results
13th Jul 20215:06 pmRNSHolding(s) in Company
30th Jun 20215:16 pmRNSHolding(s) in Company
3rd Jun 20211:27 pmRNSResult of AGM &Total Voting Rights
1st Jun 20219:49 amRNSImplementation of LTIP and Grant of Options
24th May 20218:36 amRNSHolding(s) in Company - Correction
24th May 20218:36 amRNSClarification of holding in the Company
21st May 20217:00 amRNSHolding(s) in Company -CORRECTION
19th May 20215:40 pmRNSHolding(s) in Company
7th May 20212:11 pmRNSAvailability of the Annual Report & Notice of AGM
6th May 202112:22 pmRNSHolding(s) in Company
22nd Apr 20217:00 amRNSDirector/PDMR Shareholding
20th Apr 20217:00 amRNS2020 Annual Results - Current Trading & Outlook
25th Mar 20217:00 amRNSNotice of Preliminary Results
27th Jan 20212:50 pmRNSHolding(s) in Company
26th Jan 20217:00 amRNS2020 Trading Update
14th Dec 20207:00 amRNSHolding(s) in Company
23rd Nov 20205:18 pmRNSHolding(s) in Company
10th Nov 20204:35 pmRNSPrice Monitoring Extension
5th Nov 20204:41 pmRNSSecond Price Monitoring Extn
5th Nov 20204:36 pmRNSPrice Monitoring Extension
3rd Nov 20204:41 pmRNSSecond Price Monitoring Extn
3rd Nov 20204:36 pmRNSPrice Monitoring Extension
13th Oct 20207:00 amRNSHolding(s) in Company
8th Oct 20202:31 pmRNSHolding(s) in Company
7th Oct 20201:29 pmRNSHolding(s) in Company
24th Sep 20206:03 pmRNSHolding(s) in Company
8th Sep 20207:00 amRNS2020 Half-year Report
13th Aug 20204:41 pmRNSSecond Price Monitoring Extn
13th Aug 20204:36 pmRNSPrice Monitoring Extension
7th Aug 202012:44 pmRNSHolding(s) in Company
28th Jul 20207:00 amRNSGroup Trading Update & Notice of Half-Year Results
6th Jul 20207:00 amRNSHolding(s) in Company
11th Jun 202012:45 pmRNSHolding(s) in Company
11th Jun 20207:00 amRNSResult of AGM and Total Voting Rights (TVR)
10th Jun 20207:00 amRNSAGM Statement
4th Jun 20204:41 pmRNSSecond Price Monitoring Extn
4th Jun 20204:36 pmRNSPrice Monitoring Extension
18th May 20205:44 pmRNSNotice of AGM & Posting of Annual Report
13th May 202012:39 pmRNSHolding(s) in Company
12th May 20207:00 amRNSBoard Changes
11th May 20205:29 pmRNSHolding(s) in Company
7th May 20204:55 pmRNSHolding(s) in Company
30th Apr 20207:00 amRNSAnnual results for the year ended 31 December 2019
21st Apr 20207:00 amRNSQ1 Trading update - Three months ended 31 March

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.